GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in PsoriasisNovelty and Significance
Circulation Research - United States
doi 10.1161/circresaha.116.309637
Full Text
Open PDFAbstract
Available in full text
Date
November 11, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)